Sanofi Ventures
Sanofi Ventures is the corporate venture capital arm of Sanofi, strategically investing in early-stage biotech and digital health companies. The firm focuses on transformational science and technology to improve human health, serving as an entry point to the innovation ecosystem for Sanofi. They invest across all stages of the private company lifecycle, from Seed to Series B and beyond, while leading financings, serving on boards, and working alongside portfolio companies to drive long-term value.
Sanofi Ventures
450 Water Street, Cambridge, MA 02141, USA
What We Do
Sanofi Ventures provides strategic investment in early-stage biotech and digital health companies, offering access to Sanofi’s expertise and capabilities in science, preclinical and clinical development, regulatory, data analytics, manufacturing, market access, and commercialization.
Geographic Focus
Portfolio
Curevo is advancing a non-mRNA adjuvanted subunit vaccine for shingles with improved tolerability.
#Biotechnology
Latigo is developing a pipeline of Nav1.8 inhibiting small molecules for both acute and chronic pain.
#Biotechnology
Tisento is developing Zagociguat, a first and best-in-class oral investigational medicine for mitochondrial diseases.
#Biotechnology
Fulcrum is focused on developing small molecules for genetically defined rare diseases, including losmapimod for facioscapulohumeral muscular dystrophy.
#Biopharmaceutical
Evidation captures and analyzes passive, continuous behavior data to quantify health outcomes.
#Digital Health
i2O is developing a platform for oral delivery of traditionally injectable biological drugs.
#Biotechnology